EICHORCondition: Prostate Cancer · Sponsor: Ryan J. Halter
Interested? Contact the study team ↓
This research will study a custom device developed to detect if any prostate cancer tissue is left behind when the prostate is removed. This device is called an Electrical Impedance Imaging (EII) probe.
This description comes directly from the study's public registry record.
Ryan J Halter, PhD · (603) 646-0773 · Ryan.J.Halter@dartmouth.edu
Kathy J Phipps, BA · 603 646-5793 · kathy.j.phipps@dartmouth.edu
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: 1. Clinical diagnosis of prostate cancer requiring RARP. 2. Ability to understand and the willingness to sign a written informed consent document. 3. Age ≥ 18 years old Exclusion Criteria: 1. Adults with implanted electrical devices such as pacemakers 2. Prisoners 3. Adults with impaired decision-making capacity 4. Any condition for which, in the opinion of the investigator, contraindicates study participation.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Dartmouth-Hitchcock Medical Center | Lebanon, New Hampshire, United States | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06039085